| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $10.26M | - | |
| CFO | 158.7K | $7.03M | - | |
| VP | 111.5K | $4.94M | - | |
| COO | 27.9K | $1.24M | - | |
| Dir | 25.7K | $1.14M | -2,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2019 | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sale+OE | 5,373 | $26.89 | $144,497.61 | -5.1% | |
| Apr 1, 2019 | Mitchell Paul J | Director | Sale+OE | 1,000 | $36.64 | $36,640.00 | -100% | |
| Mar 14, 2019 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 25,000 | $33.05 | $826,372.50 | -11.9% | |
| Mar 14, 2019 | Wysenski Nancy | Director | Buy | 4,302 | $33.09 | $142,339.83 | +111.5% | |
| Mar 13, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 60,000 | $33.32 | $1,998,932.42 | -4.0% | |
| Mar 7, 2019 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 20,000 | $32.07 | $641,362.00 | -9.8% | |
| Mar 5, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $33.63 | $1,681,740.00 | -6.5% | |
| Mar 1, 2019 | Mitchell Paul J | Director | Sale+OE | 1,000 | $33.48 | $33,480.00 | -100% | |
| Feb 1, 2019 | Mitchell Paul J | Director | Sale+OE | 1,000 | $32.73 | $32,730.00 | -100% | |
| Jan 4, 2019 | Mitchell Paul J | Director | Sale+OE | 1,000 | $30.00 | $30,000.00 | -100% |